How many studies have been conducted on Cefpirome?

BiohacksAI has indexed 300 PubMed studies on Cefpirome, including 16 randomized controlled trials (RCTs). 28% of studies involve human subjects.

What are the main research areas for Cefpirome?

The primary research domains for Cefpirome are 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cefpirome

A fourth-generation cephalosporin antibacterial agent. Appears to be more active in vitro against Staphylococci, some Enterococci, some ENTEROBACTERIACEAE, and PSEUDOMONAS AERUGINOSA.Cefpirome has a pyridinium group attached to C-3 position of its cephalosporin core.

300+ PubMed studies analyzed · 16 RCTs · Evidence Score: 45.4

Research Domains

Cefpirome has been studied across 7 research domains including 🫘 Kidney, 🧠 Focus & Attention, 😴 Sleep, 🫁 Respiratory, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 7% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cefpirome is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.